Skip to page body Patient Care Survivorship Research Cancer Types News Giving Community Partners Clinical Trials
UCLA's Jonsson Comprehensive Cancer Center
Take the Jonsson Cancer Center Site Survey

JCCC Member Directory

Paul Tumeh, M.D.
Paul Tumeh, M.D.

Specialty:

Dermatology

General Information:

Gender:
Male
Language(s):
English

Affiliation(s):

Clinical Instructor, Department of Medicine, Dermatology
Member, JCCC Tumor Immunology Program Area

Hospital Affiliation(s):

Ronald Reagan UCLA Medical Center
UCLA Medical Center, Santa Monica

Education:

Residency:
Dermatology, Harbor - UCLA Medical Center, 2008 - 2011
Internship:
Internal Medicine, Hospital of the University of Pennsylvania, 2005 - 2006
Medical Degree:
M.D., USC School of Medicine, 2005

Certification(s):

Medical Board Certification(s):
Dermatology, American Board of Dermatology, 2011

Contact Information:

Phone:
(310) 206-4671
Email:
Website:

Scientific Interest(s):

Dr. Paul Tumeh's research is focused on the synthesis and use of nanotechnology systems for melanoma immunotherapy.

Selected Cancer-Related Publications:

Hamid O, Robert C, Daud A, Hodi FS, Hwu WJ, Kefford R, Wolchok JD, Hersey P, Joseph RW, Weber JS, Dronca R, Gangadhar TC, Patnaik A, Zarour H, Joshua AM, Gergich K, Elassaiss-Schaap J, Algazi A, Mateus C, Boasberg P, Tumeh PC, Chmielowski B, Ebbinghaus SW, Li XN, Kang SP, Ribas A. Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma. N Engl J Med. 2013 Jul 11;369(2):134-44. doi: 10.1056/NEJMoa1305133. Epub 2013 Jun 2.

Ribas A, Tumeh PC. Cancer therapy: Tumours switch to resist. Nature. 2012 Oct 18;490(7420):347-8. doi: 10.1038/nature11489. Epub 2012 Oct 10.